The report provides revenue of the global Gene Therapy in Oncology market for the period 2016–2026, considering 2019 as the base year and 2026 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global market during the forecast period. The global Gene Therapy in Oncology market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2026.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the Gene Therapy in Oncology market across the globe.

Request Coronavirus Impact Analysis on This [email protected] www.qyresearchmedical.com/sample/57077

A comprehensive estimate on the Gene Therapy in Oncology market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Gene Therapy in Oncology during the forecast period. Price point comparison by region with global average price is also considered in the study.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Gene Therapy in Oncology market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

The global Gene Therapy in Oncology market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Gene Therapy in Oncology market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Gene Therapy in Oncology market. The authors of the report profile leading companies of the global Gene Therapy in Oncology market, such as ->

Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine, Geron Corp, Idera Pharmaceuticals, Intellia Therapeutics, Johnson & Johnson, Marsala Biotech, Merck, Mologen AG, Oncolytics Biotech, Oncosec, Oncotelic, Shenzhen SiBiono GeneTech, Sillajen Biotherapeutics, Tocagen, UniQure, Ziopharm Oncology They provide details about important activities of leading players in the competitive landscape.

Complete The Payment and Get the Full Access of [email protected] www.qyresearchmedical.com/report/checkout/57077/3500

Drivers and Restraints

This section covers the various factors driving the global Advanced Driver Assistance Systems (ADAS) market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by value and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.

Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.

Market Segmentation:

The report is divided into major categories comprising product, application, regions and others. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Every segment is studied thoroughly in order to offer a better picture to the buyers and stakeholders to benefit from. Information like highest prevailing product, highly demanded product by the application segment and end users are rightly mentioned in the Gene Therapy in Oncology report.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global Gene Therapy in Oncology market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global Gene Therapy in Oncology market.

Gene Therapy in Oncology Breakdown Data by Type
Ex Vivo
In Vivo
Gene Therapy in Oncology Breakdown Data by Application
Hospitals
Diagnostics Centers
Research Institutes

In this study, the years considered to estimate the market size of Gene Therapy in Oncology are as follows:

  • History Year: 2016-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026

Major Players Covered in this Report

The updated market research report on Gene Therapy in Oncology market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen Biotherapeutics
Tocagen
UniQure
Ziopharm Oncology

Regional Insights:

The Gene Therapy in Oncology market is segmented as North America, South America, Europe, Asia Pacific, and Middle East and Africa. Researchers have thoroughly studied about the historical market. With extensive research, experts have offered details on the current and the forecast demand made by these regions. The Gene Therapy in Oncology report also includes highlights on the prevailing product demanded by end users and end customers for better understanding of product demand by producers. This will help the producers and the marketing executives to plan their production quantity and plan effective marketing strategies to more buyers. Businesses can hence, increase their product portfolio and expand their global presence. Gene Therapy in Oncology market research report further offers information on the unexplored areas in these regions to help the producers to plan promotional strategies and create demand for their new and updated products. This will again help the manufacturers to increase their customers and emerge as leaders in the near future.

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy in Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy in Oncology Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy in Oncology Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapy in Oncology Industry
1.6.1.1 Gene Therapy in Oncology Business Impact Assessment – Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapy in Oncology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapy in Oncology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Gene Therapy in Oncology Market Perspective (2015-2026)
2.2 Gene Therapy in Oncology Growth Trends by Regions
2.2.1 Gene Therapy in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy in Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy in Oncology Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy in Oncology Players by Market Size
3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy in Oncology Market Concentration Ratio
3.2.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2019
3.3 Gene Therapy in Oncology Key Players Head office and Area Served
3.4 Key Players Gene Therapy in Oncology Product Solution and Service
3.5 Date of Enter into Gene Therapy in Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2021-2026)

5 Gene Therapy in Oncology Breakdown Data by Application (2015-2026)
5.1 Global Gene Therapy in Oncology Market Size by Application (2015-2020)
5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gene Therapy in Oncology Market Size (2015-2020)
6.2 Gene Therapy in Oncology Key Players in North America (2019-2020)
6.3 North America Gene Therapy in Oncology Market Size by Type (2015-2020)
6.4 North America Gene Therapy in Oncology Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gene Therapy in Oncology Market Size (2015-2020)
7.2 Gene Therapy in Oncology Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy in Oncology Market Size by Type (2015-2020)
7.4 Europe Gene Therapy in Oncology Market Size by Application (2015-2020)

8 China
8.1 China Gene Therapy in Oncology Market Size (2015-2020)
8.2 Gene Therapy in Oncology Key Players in China (2019-2020)
8.3 China Gene Therapy in Oncology Market Size by Type (2015-2020)
8.4 China Gene Therapy in Oncology Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gene Therapy in Oncology Market Size (2015-2020)
9.2 Gene Therapy in Oncology Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy in Oncology Market Size by Type (2015-2020)
9.4 Japan Gene Therapy in Oncology Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gene Therapy in Oncology Market Size (2015-2020)
10.2 Gene Therapy in Oncology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy in Oncology Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy in Oncology Market Size by Application (2015-2020)

11 India
11.1 India Gene Therapy in Oncology Market Size (2015-2020)
11.2 Gene Therapy in Oncology Key Players in India (2019-2020)
11.3 India Gene Therapy in Oncology Market Size by Type (2015-2020)
11.4 India Gene Therapy in Oncology Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gene Therapy in Oncology Market Size (2015-2020)
12.2 Gene Therapy in Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy in Oncology Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy in Oncology Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
13.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Cold Genesys
13.2.1 Cold Genesys Company Details
13.2.2 Cold Genesys Business Overview and Its Total Revenue
13.2.3 Cold Genesys Gene Therapy in Oncology Introduction
13.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2015-2020)
13.2.5 Cold Genesys Recent Development
13.3 Advantagene
13.3.1 Advantagene Company Details
13.3.2 Advantagene Business Overview and Its Total Revenue
13.3.3 Advantagene Gene Therapy in Oncology Introduction
13.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2015-2020)
13.3.5 Advantagene Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview and Its Total Revenue
13.4.3 Amgen Gene Therapy in Oncology Introduction
13.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview and Its Total Revenue
13.5.3 AstraZeneca Gene Therapy in Oncology Introduction
13.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bio-Path Holdings
13.6.1 Bio-Path Holdings Company Details
13.6.2 Bio-Path Holdings Business Overview and Its Total Revenue
13.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
13.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2015-2020)
13.6.5 Bio-Path Holdings Recent Development
13.7 CRISPR Therapeutics
13.7.1 CRISPR Therapeutics Company Details
13.7.2 CRISPR Therapeutics Business Overview and Its Total Revenue
13.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
13.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
13.7.5 CRISPR Therapeutics Recent Development
13.8 Editas Medicine
13.8.1 Editas Medicine Company Details
13.8.2 Editas Medicine Business Overview and Its Total Revenue
13.8.3 Editas Medicine Gene Therapy in Oncology Introduction
13.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2015-2020)
13.8.5 Editas Medicine Recent Development
13.9 Geron Corp
13.9.1 Geron Corp Company Details
13.9.2 Geron Corp Business Overview and Its Total Revenue
13.9.3 Geron Corp Gene Therapy in Oncology Introduction
13.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2015-2020)
13.9.5 Geron Corp Recent Development
13.10 Idera Pharmaceuticals
13.10.1 Idera Pharmaceuticals Company Details
13.10.2 Idera Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
13.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2015-2020)
13.10.5 Idera Pharmaceuticals Recent Development
13.11 Intellia Therapeutics
10.11.1 Intellia Therapeutics Company Details
10.11.2 Intellia Therapeutics Business Overview and Its Total Revenue
10.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
10.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.11.5 Intellia Therapeutics Recent Development
13.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Details
10.12.2 Johnson & Johnson Business Overview and Its Total Revenue
10.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
10.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2015-2020)
10.12.5 Johnson & Johnson Recent Development
13.13 Marsala Biotech
10.13.1 Marsala Biotech Company Details
10.13.2 Marsala Biotech Business Overview and Its Total Revenue
10.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
10.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.13.5 Marsala Biotech Recent Development
13.14 Merck
10.14.1 Merck Company Details
10.14.2 Merck Business Overview and Its Total Revenue
10.14.3 Merck Gene Therapy in Oncology Introduction
10.14.4 Merck Revenue in Gene Therapy in Oncology Business (2015-2020)
10.14.5 Merck Recent Development
13.15 Mologen AG
10.15.1 Mologen AG Company Details
10.15.2 Mologen AG Business Overview and Its Total Revenue
10.15.3 Mologen AG Gene Therapy in Oncology Introduction
10.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2015-2020)
10.15.5 Mologen AG Recent Development
13.16 Oncolytics Biotech
10.16.1 Oncolytics Biotech Company Details
10.16.2 Oncolytics Biotech Business Overview and Its Total Revenue
10.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
10.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.16.5 Oncolytics Biotech Recent Development
13.17 Oncosec
10.17.1 Oncosec Company Details
10.17.2 Oncosec Business Overview and Its Total Revenue
10.17.3 Oncosec Gene Therapy in Oncology Introduction
10.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2015-2020)
10.17.5 Oncosec Recent Development
13.18 Oncotelic
10.18.1 Oncotelic Company Details
10.18.2 Oncotelic Business Overview and Its Total Revenue
10.18.3 Oncotelic Gene Therapy in Oncology Introduction
10.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2015-2020)
10.18.5 Oncotelic Recent Development
13.19 Shenzhen SiBiono GeneTech
10.19.1 Shenzhen SiBiono GeneTech Company Details
10.19.2 Shenzhen SiBiono GeneTech Business Overview and Its Total Revenue
10.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
10.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.19.5 Shenzhen SiBiono GeneTech Recent Development
13.20 Sillajen Biotherapeutics
10.20.1 Sillajen Biotherapeutics Company Details
10.20.2 Sillajen Biotherapeutics Business Overview and Its Total Revenue
10.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Introduction
10.20.4 Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.20.5 Sillajen Biotherapeutics Recent Development
13.21 Tocagen
10.21.1 Tocagen Company Details
10.21.2 Tocagen Business Overview and Its Total Revenue
10.21.3 Tocagen Gene Therapy in Oncology Introduction
10.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2015-2020)
10.21.5 Tocagen Recent Development
13.22 UniQure
10.22.1 UniQure Company Details
10.22.2 UniQure Business Overview and Its Total Revenue
10.22.3 UniQure Gene Therapy in Oncology Introduction
10.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2015-2020)
10.22.5 UniQure Recent Development
13.23 Ziopharm Oncology
10.23.1 Ziopharm Oncology Company Details
10.23.2 Ziopharm Oncology Business Overview and Its Total Revenue
10.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
10.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2015-2020)
10.23.5 Ziopharm Oncology Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

Complete The Payment and Get the Full Access of [email protected] www.qyresearchmedical.com/report/checkout/57077/3500

Contact Us:

QYResearch Medical

URL – www.qyresearchmedical.com/

Mailing Address : Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Any Assistance, Email – [email protected]



Source link